Contract 75A50325C00012
Chartwell Rx Llc · Department Of Health And Human Services · August 27, 2025
Chartwell Rx Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 27, 2025 for $16.08 million of work in pharmaceutical preparation manufacturing. Performance is in Congers, NY. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $42.79 million.
Contract details
- PIID
- 75A50325C00012
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Congers, NY
- First action
- August 27, 2025
Description
BULK PHARMA - GROUP A (ASSET MGMT) DOXYCYCLINE 25MG/5ML ORAL SUSPENSION, POWDER, 60ML BOTTLE, ONDANSETRON HCL 8MG, 30 TABLETS, BOTTLE
Modification timeline
-
August 27, 2025Base award$16.08M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325C00012?
Contract 75A50325C00012 is a federal contract awarded to Chartwell Rx Llc by Department Of Health And Human Services on August 27, 2025 for $16.08 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75A50325C00012?
Chartwell Rx Llc won contract 75A50325C00012 from Department Of Health And Human Services.
How much is contract 75A50325C00012 worth?
Contract 75A50325C00012 has obligated $16.08 million to date, with a total potential value of $42.79 million if all options are exercised.